Clinical Trials Logo
  1. Home
  2. Hemolytic-uremic Syndrome
  3. NCT01406288

Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4 — SHU O104 CUB  

Escherichia Coli Infections Clinical Trial

Official title:
Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4 in Bordeaux Urban Area, June 2011: Evaluation of Diagnostic, Prognostic and Pathophysiological Data

Clinical Trial Summary

The Hemolytic Uremic Syndrome (HUS) in its typical form occurs after a food born infection with a shiga-toxin secreting bacteria, usually Escherichia coli of the O157H7 serotype. An outbreak of bloody diarrhea followed by HUS begun after a collective meal with 120 persons on June 8th, 2011 in Bègles, a city of Bordeaux urban area (CUB).

At least 9 patients, 8 adults and 1 child have been involved in this HUS outbreak, E. coli of the O104:H4 serotype being demonstrated in most patients. This outbreak is remarkable by its preponderance in adults and women, its aggressiveness with multiorgan involvement , i.e. the kidneys, brain, liver, pancreas, and skin.

Pathophysiology, prognosis, and treatment of typical HUS are poorly defined, particularly in adults who are usually not involved in typical E. coli O157H7 HUS.

The aim of the present study is to gain knowledge on these different aspects of the HUS, including response to therapy.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01406288
Study type Observational
Source University Hospital, Bordeaux
Contact
Status Completed
Phase N/A
Start date July 2011
Completion date March 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT02541695 - Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli N/A
Completed NCT03303937 - Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care Patients N/A
Not yet recruiting NCT03869593 - Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria
Completed NCT02853708 - Epidemiology of ST131 in Besançon University Hospital N/A
Active, not recruiting NCT02729116 - Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients Phase 2/Phase 3
Completed NCT01324726 - Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms N/A
Not yet recruiting NCT03800147 - Effects of Nutritional Fat on the Growth of Intestinal E. Coli N/A
Completed NCT00167986 - Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care Phase 4
Terminated NCT00362869 - Enteroaggregative E.Coli (EAEC) Phase 1
Completed NCT00167999 - Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units Phase 4
Completed NCT06252428 - Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals